wsava
vaccin
guidelin
group
vgg
conven
order
develop
guidelin
vaccin
dog
cat
global
applic
first
version
guidelin
publish
updat
present
document
provid
updat
expand
version
intern
guidelin
vaccin
small
companion
anim
indic
scientif
evid
base
recommend
made
vgg
recognis
keep
pet
small
anim
subject
signific
variat
practic
associ
econom
throughout
world
vaccin
recommend
might
appli
develop
countri
may
appropri
develop
countri
guidelin
mandatori
edict
rather
use
nation
associ
individu
veterinari
practic
develop
vaccin
schedul
relev
local
situat
howev
vgg
strongli
recommend
wherev
possibl
dog
cat
receiv
benefit
vaccin
protect
individu
anim
provid
optimum
herd
immun
minim
likelihood
infecti
diseas
outbreak
background
mind
vgg
defin
core
vaccin
dog
cat
regardless
circumst
geograph
locat
receiv
core
vaccin
protect
anim
sever
diseas
global
distribut
core
vaccin
dog
protect
canin
distemp
viru
cdv
canin
adenoviru
cav
variant
canin
parvoviru
type
core
vaccin
cat
protect
felin
parvoviru
fpv
felin
caliciviru
fcv
felin
area
world
rabi
viru
infect
endem
vaccin
agent
consid
core
speci
even
legal
requir
routin
vaccin
vgg
recogn
matern
deriv
antibodi
mda
significantli
interfer
efficaci
current
core
vaccin
administ
pup
kitten
earli
life
level
mda
vari
significantli
among
litter
vgg
recommend
administr
multipl
core
vaccin
dose
pup
kitten
final
dose
deliv
week
older
follow
booster
age
cultur
financi
situat
pet
anim
may
permit
benefit
singl
vaccin
vaccin
core
vaccin
week
age
older
vgg
support
use
simpl
test
determin
seroconvers
core
vaccin
compon
cdv
cav
fpv
follow
vaccin
determin
seroprotect
adult
dog
manag
infecti
diseas
outbreak
shelter
vaccin
given
needlessli
core
vaccin
given
frequent
everi
three
year
booster
inject
follow
puppykitten
seri
durat
immun
doi
mani
year
may
lifetim
pet
vgg
defin
vaccin
requir
anim
whose
geograph
locat
local
environ
lifestyl
place
risk
contract
specif
infect
vgg
also
classifi
vaccin
recommend
insuffici
scientif
evid
justifi
use
consid
number
minor
product
restrict
geograph
avail
applic
vgg
strongli
support
concept
regular
usual
annual
health
check
remov
emphasi
client
expect
annual
revaccin
annual
health
check
may
still
encompass
administr
select
vaccin
administ
annual
doi
product
gener
year
vgg
consid
use
vaccin
shelter
environ
recogn
particular
circumst
establish
financi
constraint
sometim
oper
vgg
minimum
shelter
guidelin
simpl
dog
cat
enter
establish
vaccin
time
entri
core
vaccin
financ
permit
repeat
core
vaccin
administ
per
schedul
defin
guidelin
vaccin
respiratori
diseas
may
includ
vgg
recogn
import
advers
reaction
report
scheme
understand
variabl
develop
differ
countri
wherev
possibl
veterinarian
activ
encourag
report
possibl
advers
event
manufactur
andor
regulatori
author
expand
knowledg
base
drive
develop
improv
vaccin
safeti
fundament
concept
propos
vgg
may
encapsul
follow
statement
aim
vaccin
everi
anim
core
vaccin
vaccin
given
frequent
deem
necessari
wsava
vaccin
guidelin
group
vgg
conven
aim
produc
global
vaccin
guidelin
dog
cat
would
consid
intern
differ
econom
societ
factor
impact
keep
small
companion
anim
wsava
guidelin
therefor
intend
much
broader
scope
produc
north
america
american
academi
felin
practition
scherk
et
al
american
anim
hospit
associ
welborn
et
al
europ
advisori
board
cat
diseas
hosi
et
al
first
wsava
guidelin
publish
day
et
al
updat
day
et
al
accompani
document
written
owner
breeder
pet
dog
cat
vgg
focus
dog
cat
infecti
diseas
vaccinolog
asian
contin
produc
region
recommend
aspect
vaccin
asian
practition
day
et
al
vgg
work
updat
global
canin
felin
vaccin
guidelin
present
document
format
much
content
revis
remain
similar
guidelin
publish
howev
specif
chang
current
document
includ
explicit
attent
demonstr
approach
wsava
recommend
develop
new
classif
scheme
evid
relat
vaccinolog
complet
referenc
pertin
scientif
literaturechang
recommend
made
time
core
vaccin
puppi
kitten
take
account
new
data
persist
antibodi
mda
anim
specif
time
final
vaccin
puppi
kitten
seri
extend
week
age
olderchang
recommend
booster
vaccin
puppi
kitten
provid
option
reduc
interv
month
week
ageclarif
discuss
revaccin
interv
adult
cat
receiv
modifi
live
viru
mlv
vaccin
felin
herpesviru
felin
caliciviru
fcv
inclus
inform
concern
newli
avail
vaccin
eg
oral
bordetella
bronchiseptica
vaccin
dog
fcv
vaccin
contain
two
strain
viru
leptospira
vaccin
reclassif
felin
immunodefici
viru
fiv
vaccin
time
core
vaccin
puppi
kitten
shelter
settingan
extend
discuss
use
serolog
test
antibodi
specif
core
vaccin
antigen
includ
applic
test
manag
shelter
outbreak
infecti
diseasefurth
consider
optimum
anatom
site
vaccin
catsupd
vgg
diseas
fact
sheet
expans
list
frequent
ask
question
concept
veterinari
medicin
ebvm
becom
increasingli
promin
sinc
wsava
vaccin
guidelin
first
publish
categori
defin
weight
evid
underli
procedur
veterinari
practic
eg
medic
surgic
diagnost
procedur
administr
pharmaceut
defin
appli
previous
european
recommend
felin
vaccin
lloret
vgg
aim
current
updat
wsava
global
vaccin
guidelin
adopt
explicitli
approach
practition
could
made
awar
natur
evid
underpin
recommend
made
accordingli
document
fulli
referenc
previou
iter
guidelin
addit
vgg
wish
appli
rank
support
evid
found
current
use
scheme
poorli
applic
specialist
area
vaccinolog
reason
vgg
develop
ebvm
classif
propos
four
level
evid
relat
investig
small
companion
anim
vaccin
categori
evid
recommend
support
scientif
public
either
experiment
field
data
evid
within
categori
might
still
variabl
scientif
qualiti
despit
peer
review
peer
review
process
conform
univers
standard
categori
evid
recommend
support
unpublish
commerci
sensit
studi
submit
part
regulatori
packag
licens
veterinari
vaccin
assumpt
level
evid
inform
appear
datasheet
licens
product
compet
peer
review
regulatori
author
categori
evid
recommend
support
commerci
independ
experiment
field
data
publish
peer
review
scientif
literatur
includ
formal
regulatori
packag
subject
scrutini
regul
categori
evid
recommend
unsupport
experiment
field
data
assum
knowledg
first
principl
microbiolog
immunolog
support
expert
opinion
throughout
document
statement
may
follow
qualifi
reflect
evid
base
categori
respect
occas
use
rigor
level
evid
avail
given
wsava
vaccin
guidelin
serv
set
rule
administr
vaccin
dog
cat
simpli
possibl
produc
set
guidelin
appli
equal
wsava
member
nation
vast
differ
countri
geograph
region
respect
infecti
diseas
presenceabs
preval
vaccin
product
avail
own
versu
dog
cat
popul
practic
client
econom
societ
attitud
instead
guidelin
intend
provid
nation
small
anim
veterinari
associ
wsava
member
current
scientif
advic
best
practic
vaccin
concept
nation
associ
individu
practic
read
discuss
adapt
guidelin
particular
practic
situat
guidelin
proscript
exampl
entir
possibl
might
consid
vaccin
mani
countri
particular
geograph
region
might
use
core
vaccin
elsewher
practition
sometim
alarm
guidelin
recommend
appear
contrari
given
product
datasheet
summari
product
characterist
spc
europ
therefor
feel
adopt
guidelin
recommend
leav
open
litig
distinct
differ
datasheet
guidelin
document
clearli
discuss
thiri
horzinek
data
sheet
spc
document
form
part
registr
process
specif
vaccin
datasheet
give
detail
qualiti
safeti
efficaci
product
case
vaccin
describ
minimum
durat
immun
doi
product
doi
base
experiment
evid
ie
long
vaccin
anim
protect
infect
diseas
determin
challeng
virul
infecti
agent
repres
minimum
valu
need
reflect
true
doi
vaccin
companion
anim
core
vaccin
rel
recent
minimum
doi
carri
recommend
annual
revaccin
recent
year
mani
product
licens
minimum
doi
sometim
year
fact
mani
countri
major
core
mlv
vaccin
licens
triennial
revaccin
adult
anim
howev
mani
countri
ident
product
still
carri
minimum
doi
simpli
manufactur
appli
chang
product
label
recommend
nation
licens
author
permit
chang
made
unfortun
situat
lead
confus
amongst
practition
countri
must
rememb
even
licens
minimum
doi
core
vaccin
core
vaccin
true
doi
like
consider
longer
lifelong
major
vaccin
recipi
therefor
remain
instanc
guidelin
may
recommend
triennial
less
frequent
revaccin
avail
product
particular
countri
still
carri
licens
doi
instanc
veterinarian
may
use
vaccin
accord
guidelin
therefor
current
scientif
think
obtain
inform
document
owner
consent
deviat
manufactur
recommend
use
veterinarian
also
awar
compani
technic
repres
continu
advis
veterinarian
must
adher
recommend
given
datasheet
oblig
sinc
document
licens
procedur
confus
may
aris
veterinarian
compar
recommend
given
differ
set
guidelin
exampl
subtl
differ
recommend
made
differ
countri
reflect
differ
opinion
local
expert
group
preval
particular
infecti
diseas
typic
lifestyl
pet
anim
may
make
less
expos
infect
vgg
face
difficult
challeng
set
variou
nation
region
guidelin
recommend
attempt
provid
balanc
perspect
account
global
differ
keep
small
companion
anim
summari
veterinarian
feel
comfort
vaccin
accord
schedul
given
guidelin
local
recommend
avail
vgg
recommend
differ
current
product
label
recommend
practition
need
sure
obtain
inform
client
consent
order
use
vaccin
accord
vgg
recommend
vaccin
success
necessari
continu
vaccin
practic
littl
doubt
develop
countri
major
infecti
diseas
dog
cat
consid
uncommon
pet
popul
howev
even
countri
remain
geograph
pocket
infect
sporad
outbreak
diseas
may
occur
situat
regard
shelter
popul
distinctli
differ
own
pet
anim
mani
develop
countri
key
infecti
diseas
remain
common
develop
nation
major
caus
mortal
small
anim
although
difficult
obtain
accur
figur
even
develop
countri
estim
pet
anim
popul
vaccin
significantli
less
develop
nation
global
econom
recess
impact
uptak
prevent
healthcar
pet
owner
develop
countri
survey
data
suggest
recent
declin
vaccin
anon
small
anim
medicin
slow
grasp
concept
herd
immun
vaccin
individu
pet
anim
import
protect
individu
reduc
number
suscept
anim
region
popul
thu
preval
diseas
herd
immun
relat
use
core
vaccin
provid
long
mani
year
doi
highli
depend
percentag
anim
popul
vaccin
number
vaccin
occur
annual
therefor
everi
effort
made
vaccin
higher
percentag
cat
dog
core
vaccin
simpli
possibl
induc
better
immun
individu
anim
give
repeat
vaccin
ie
dog
receiv
core
mlv
vaccin
everi
year
equal
well
protect
compar
one
receiv
vaccin
annual
bohm
et
al
mouzin
et
al
mitchel
et
al
may
necessarili
case
felin
core
vaccin
see
recent
year
concept
one
health
also
impact
field
vaccinolog
manag
infecti
diseas
collabor
interact
human
medic
anim
environment
healthcar
profession
provid
ration
goal
time
major
newli
emerg
human
infecti
diseas
propos
deriv
wild
domest
anim
sourc
gibb
wsava
embrac
one
health
concept
establish
one
health
committe
day
work
overlap
vgg
tackl
major
small
companion
anim
zoonos
canin
rabi
leishmaniosi
second
major
concept
regard
vaccin
dog
cat
recognit
aim
reduc
vaccin
load
individu
anim
order
minim
potenti
advers
reaction
vaccin
product
reduc
time
financi
burden
client
veterinarian
unjustifi
veterinari
medic
procedur
reason
seen
develop
vaccin
guidelin
base
ration
analysi
vaccin
requir
pet
propos
vaccin
consid
core
natur
extent
categor
product
base
avail
scientif
evid
person
experi
concert
effort
introduc
effect
companion
anim
diseas
surveil
global
scale
would
provid
definit
basi
recommend
vaccin
usag
day
et
al
parallel
categor
vaccin
push
toward
market
product
extend
doi
reduc
unnecessari
administr
vaccin
therebi
improv
vaccin
safeti
chang
necessit
veterinari
practition
becom
accept
norm
mani
countri
follow
vgg
guidelin
prepar
consid
optimum
model
commit
pet
owner
will
abl
bring
anim
veterinarian
full
recommend
cours
vaccin
vgg
awar
less
commit
abl
pet
owner
everi
countri
countri
sever
financi
societ
constraint
often
determin
natur
vaccin
cours
administ
situat
exampl
decis
must
made
individu
pet
may
receiv
singl
core
vaccin
lifetim
vgg
would
emphasis
optim
given
time
anim
capabl
respond
immunolog
ie
greater
week
age
vgg
addit
consid
vaccin
shelter
situat
guidelin
propos
consid
provid
optimum
level
protect
highli
suscept
anim
vgg
also
recognis
mani
shelter
run
limit
financi
support
may
constrain
extent
vaccin
use
minimum
vaccin
protocol
situat
would
singl
administr
core
vaccin
time
admiss
shelter
document
seek
address
current
issu
canin
felin
vaccinolog
suggest
practic
measur
veterinari
profess
may
move
toward
ration
use
vaccin
speci
import
messag
vgg
therefor
encapsul
follow
statement
aim
vaccin
everi
anim
core
vaccin
vaccin
given
frequent
deem
necessari
discuss
specif
vaccin
guidelin
brief
review
type
small
companion
anim
vaccin
avail
justifi
vaccin
may
consid
simpli
either
infecti
natur
infecti
vaccin
use
dog
cat
contain
organ
attenu
reduc
virul
ie
modifi
live
viru
mlv
attenu
vaccin
organ
intact
viabl
induc
immun
induc
infect
replic
within
anim
without
produc
signific
tissu
patholog
clinic
sign
infecti
diseas
infecti
vaccin
advantag
effect
induc
immun
relev
anatom
site
administ
parenter
like
induc
robust
humor
immun
infecti
vaccin
administ
directli
mucos
site
ie
intranas
oral
vaccin
even
effect
induc
relev
protect
mucos
immun
recombin
vector
vaccin
ie
live
vector
organ
carri
genet
materi
encod
antigen
target
pathogen
may
also
consid
infecti
howev
vector
organ
relev
pathogen
dog
cat
administ
anim
lack
antibodi
mda
infecti
vaccin
gener
induc
protect
singl
dose
vaccin
also
known
kill
inactiv
vaccin
includ
subunit
nake
dna
vaccin
contain
inactiv
antigen
intact
viru
organ
natur
synthet
antigen
deriv
viru
organ
dna
encod
antigen
agent
unabl
infect
replic
induc
patholog
clinic
sign
infecti
diseas
gener
requir
adjuv
increas
potenc
usual
requir
multipl
dose
even
adult
anim
induc
protect
vaccin
administ
parenter
may
less
like
induc
humor
immun
gener
shorter
doi
compar
infecti
vaccin
guidelin
recommend
core
recommend
option
recommend
vaccin
gener
veterinari
practic
given
tabl
vgg
consid
core
vaccin
one
dog
throughout
world
must
receiv
recommend
interv
order
provid
protect
infecti
diseas
global
signific
core
vaccin
dog
confer
protect
infect
canin
distemp
viru
cdv
canin
adenoviru
cav
type
canin
parvoviru
type
variant
vgg
recogn
particular
countri
identifi
addit
vaccin
consid
core
particular
exampl
vaccin
may
consid
core
countri
rabi
viru
geograph
area
infect
endem
dog
vaccin
routin
protect
pet
human
popul
vgg
strongli
endors
joint
statement
wsava
one
health
committe
intern
organis
anim
health
oie
set
target
global
elimin
canin
rabi
anon
mani
countri
rabi
vaccin
legal
requir
gener
also
requir
intern
pet
travel
vaccin
use
determin
basi
geograph
lifestyl
exposur
risk
individu
assess
ratio
ie
risk
unvaccin
suscept
risk
vaccin
develop
advers
reaction
versu
benefit
protect
infect
question
recommend
vaccin
littl
scientif
justif
insuffici
evid
base
use
puppi
protect
mda
first
week
life
puppi
passiv
immun
wane
week
age
level
allow
activ
immun
puppi
poor
mda
may
vulner
capabl
respond
vaccin
earlier
age
other
may
possess
mda
high
titr
incap
respond
vaccin
week
age
friedrich
truyen
singl
primari
vaccin
polici
therefor
cover
possibl
situat
recommend
vgg
initi
core
vaccin
week
age
everi
week
week
age
older
therefor
number
puppi
primari
core
vaccin
determin
age
vaccin
start
select
interv
vaccin
possibl
schedul
outlin
tabl
recommend
vaccin
start
week
age
cours
four
primari
core
vaccin
would
administ
interv
three
would
requir
start
similar
interv
contrast
mani
vaccin
datasheet
continu
recommend
initi
cours
two
inject
core
vaccin
product
also
licens
week
finish
design
second
two
core
vaccin
given
week
age
rational
behind
protocol
permit
earli
social
puppi
diminish
risk
infecti
diseas
vgg
recogn
earli
social
essenti
behaviour
develop
dog
korbelik
et
al
avsab
protocol
ie
puppi
class
adopt
vigil
still
maintain
owner
allow
restrict
exposur
puppi
control
area
puppi
adult
appear
healthi
fulli
vaccin
particular
puppi
class
held
venu
away
veterinari
practic
altern
decid
veterinari
premis
must
use
floor
clean
disinfect
class
class
held
area
highli
traffick
dog
unknown
vaccin
diseas
statu
recent
us
studi
shown
minim
risk
amongst
vaccin
puppi
attend
social
class
stepita
et
al
vgg
recommend
whenev
possibl
last
puppi
primari
seri
core
vaccin
given
week
age
older
integr
part
core
vaccin
puppi
booster
vaccin
tradit
given
either
month
age
month
last
primari
seri
puppi
vaccin
main
aim
vaccin
ensur
protect
immun
respons
develop
dog
may
fail
respond
vaccin
primari
core
seri
rather
necessarili
boost
immun
respons
deliveri
vaccin
month
age
like
chosen
histor
conveni
time
request
owner
attend
practic
first
annual
health
check
therefor
impli
individu
puppi
fail
respond
primari
core
vaccin
puppi
may
unprotect
receiv
vaccin
might
account
occurr
infecti
diseas
eg
canin
parvovir
enter
proport
vaccin
puppi
less
month
age
vgg
practic
suggest
veterinarian
might
wish
reduc
possibl
window
suscept
bring
forward
vaccin
week
week
age
inde
time
point
week
age
howev
week
age
provid
conveni
time
practic
requir
pet
owner
clearli
understand
recommend
indic
tabl
adopt
protocol
mean
vaccin
start
week
old
puppi
might
entail
five
vaccin
visit
first
month
life
core
vaccin
week
booster
anoth
core
vaccin
would
requir
least
anoth
year
new
recommend
vaccin
month
age
altern
vaccin
year
age
certainli
mutual
exclus
preclud
first
annual
health
check
mani
veterinarian
understand
keen
check
anim
care
around
time
reach
skelet
matur
dog
respond
vaccin
mlv
core
vaccin
maintain
solid
immun
immunolog
memori
mani
year
absenc
repeat
vaccin
bohm
et
al
mouzin
et
al
schultz
mitchel
et
al
follow
week
booster
subsequ
revaccin
given
interv
year
longer
emphas
triennial
adult
revaccin
gener
appli
kill
core
vaccin
except
rabi
vaccin
particularli
vaccin
contain
bacteri
antigen
thu
leptospira
bordetella
borrelia
lyme
diseas
product
also
parainfluenza
viru
compon
requir
frequent
booster
reliabl
protect
elli
krakowka
klaasen
et
al
elli
schuller
et
al
therefor
adult
dog
may
accord
guidelin
still
revaccin
annual
compon
vaccin
may
differ
year
typic
core
vaccin
current
administ
triennial
chosen
product
given
annual
vgg
awar
countri
product
contain
core
combin
avail
vgg
would
encourag
manufactur
make
full
rang
vaccin
least
separ
core
vaccin
mitchel
et
al
avail
wherev
possibl
adult
dog
receiv
complet
cours
core
vaccin
puppi
includ
week
booster
may
vaccin
regularli
adult
requir
singl
dose
mlv
core
vaccin
boost
immun
mouzin
et
al
mitchel
et
al
similarli
adopt
adult
dog
puppi
week
age
unknown
vaccin
histori
requir
singl
dose
mlv
core
vaccin
engend
protect
immun
respons
mani
vaccin
datasheet
advis
circumst
dog
requir
two
vaccin
puppi
practic
unjustifi
contrari
fundament
immunolog
principl
note
appli
vaccin
mani
requir
two
dose
adult
dog
particular
mention
made
canin
rabi
vaccin
vgg
recommend
countri
canin
rabi
endem
vaccin
dog
strongli
recommend
client
veterinarian
even
requir
law
revaccin
interv
canin
rabi
often
mandat
law
intern
avail
kill
rabi
vaccin
initi
produc
licens
doi
statut
requir
annual
revaccin
product
carri
doi
mani
countri
law
modifi
incorpor
chang
howev
countri
legal
requir
odd
vaccin
licens
other
neither
vaccin
licens
law
chang
final
countri
also
rabi
vaccin
doi
like
safe
extend
year
veterinarian
mind
law
access
product
confer
minimum
immun
nation
associ
might
lobbi
law
chang
match
current
scientif
evid
common
reason
vaccin
failur
howev
last
vaccin
dose
given
week
age
older
mda
decreas
low
level
friedrich
truyen
activ
immun
succeed
puppi
poor
immunogen
may
reflect
rang
factor
stage
vaccin
design
manufactur
administr
anim
exampl
viru
strain
passag
histori
product
error
manufactur
particular
batch
product
may
caus
vaccin
failur
realiti
effect
rare
affect
vaccin
produc
larg
manufactur
market
vaccin
intern
manufactur
strict
requir
govern
regulatori
agenc
batch
potenc
test
releas
factor
incorrect
storag
transport
interrupt
cold
chain
handl
disinfect
use
vaccin
veterinari
practic
may
result
inactiv
mlv
product
vgg
recogn
vaccin
husbandri
remain
issu
mani
countri
includ
simpl
guidelin
tabl
anim
fail
develop
antibodi
respons
repeat
revaccin
consid
genet
immunolog
genet
control
speci
certain
breed
dog
suspect
believ
unproven
high
suscept
recogn
certain
rottweil
dobermann
regardless
vaccin
histori
relat
part
high
preval
houston
et
al
usa
today
two
breed
seem
greater
number
breed
possibl
carrier
genet
trait
may
die
infect
dog
breed
may
low
antigen
exampl
uk
germani
phenotyp
remain
preval
amongst
rottweil
recent
studi
shown
breed
higher
proport
anim
fail
achiev
titr
rabi
antibodi
requir
pet
travel
kennedi
et
al
broad
estim
made
proport
genet
canin
popul
everi
dog
cdv
everi
dog
cav
everi
dog
antibodi
test
use
demonstr
doi
vaccin
core
vaccin
known
larg
major
dog
maintain
protect
antibodi
cdv
mani
year
numer
experiment
studi
support
observ
bohm
et
al
mouzin
et
al
schultz
mitchel
et
al
therefor
antibodi
absent
irrespect
serolog
test
use
dog
revaccin
unless
medic
reason
even
though
protect
immunolog
memori
antibodi
determin
vaccin
compon
limit
valu
short
time
period
antibodi
persist
eg
leptospira
product
lack
correl
serum
antibodi
protect
eg
leptospira
canin
parainfluenza
hartman
et
al
klaasen
et
al
elli
krakowka
martin
et
al
vgg
recogn
present
serolog
test
might
rel
expens
howev
principl
veterinari
medicin
suggest
test
antibodi
statu
either
puppi
adult
dog
better
practic
simpli
administ
vaccin
booster
basi
would
safe
cost
less
vaccin
ie
activ
immun
domin
infecti
diseas
prevent
passiv
immun
continu
use
treatment
infecti
diseas
mani
countri
although
viru
infect
trigger
cellular
humor
immun
mainli
antibodi
respons
contribut
reduct
viral
load
recoveri
mani
viru
infect
antibodi
level
therefor
taken
correl
protect
viraemia
inject
antibodi
direct
surfac
structur
virion
bind
particl
neutral
infect
prepar
remov
therapeut
serum
immunoglobulin
prepar
use
passiv
immun
inject
subcutan
differ
anim
speci
quickli
reach
circul
unexpectedli
intraven
infus
plasma
serum
speci
found
work
well
local
infect
initi
bite
rabid
carnivor
antibodi
prophylaxi
also
proven
invalu
human
medicin
human
rabi
immun
globulin
provid
rapid
protect
given
first
day
prophylaxi
regimen
much
possibl
prepar
infiltr
around
wound
may
given
intramuscularli
site
distant
rabi
vaccin
appli
simultan
companion
anim
practic
prevent
activ
immun
commonplac
serum
prophylaxistherapi
consid
except
circumst
eg
dog
present
distemp
cat
present
panleukopenia
diseas
outbreak
kennelcatteri
still
market
serum
immunoglobulin
product
compani
produc
exist
usa
germani
czech
republ
slovakia
russia
brazil
prepar
either
homolog
heterolog
eg
hors
origin
polyval
direct
sever
virus
consist
sera
immunoglobulin
fraction
despit
avail
product
vgg
recommend
use
conserv
care
consider
case
outbreak
cdv
infect
kennel
much
safer
effect
vaccin
dog
cdv
vaccin
rather
give
immun
serum
see
tabl
larson
schultz
situat
previous
recommend
mlv
vaccin
administ
intraven
rather
subcutan
intramuscularli
littl
evid
practic
provid
effect
rapid
protect
subcutan
intramuscular
inject
administr
cdv
vaccin
rout
provid
protect
sever
diseas
death
immedi
shortli
vaccin
instanc
vaccin
prevent
infect
instead
protect
sever
diseas
especi
neurolog
diseas
anim
surviv
subsequ
immun
life
case
catteri
outbreak
fpv
infect
kennel
outbreak
infect
recent
studi
shown
immun
plasma
given
clinic
sign
appear
benefit
reduct
morbid
mortal
bragg
et
al
howev
work
criticis
small
volum
ml
immun
plasma
given
puppi
studi
much
larger
volum
mlkg
routin
use
research
practition
larg
dose
believ
experienc
clinician
investig
efficaci
dodd
order
maxim
benefici
effect
immun
serum
plasma
must
given
infect
prior
onset
clinic
sign
case
administr
immun
serum
plasma
best
provid
within
hour
infect
larg
amount
high
titr
serum
plasma
requir
serum
plasma
must
given
parenter
eg
subcutan
intraven
intraperiton
oral
benefit
oral
administr
even
treatment
start
prior
infect
import
consider
shelter
situat
rel
cost
commerci
product
altern
practic
sometim
use
shelter
situat
collect
serum
plasma
anim
shelter
surviv
diseas
recent
vaccin
howev
practic
carri
risk
serum
necessarili
screen
transmiss
pathogen
eg
haemoparasit
felin
retrovirus
serolog
test
provid
effect
approach
control
diseas
outbreak
shelter
situat
see
tabl
sinc
public
wsava
guidelin
newli
introduc
vaccin
includ
bordetella
bronchiseptica
vaccin
oral
administr
hess
et
al
elli
global
increas
rang
leptospira
vaccin
contain
multipl
geograph
relev
serogroup
klaasen
et
al
wilson
et
al
schuller
et
al
product
describ
tabl
vaccin
canin
influenza
viru
civ
infect
licens
usa
deshpand
et
al
larson
et
al
influenza
subtyp
well
recogn
caus
respiratori
diseas
north
american
dog
hous
togeth
crawford
et
al
payungporn
et
al
castleman
et
al
date
sporad
outbreak
recogn
report
elsewher
crawford
et
al
dali
et
al
kirkland
et
al
pratelli
colao
schulz
et
al
civ
vaccin
contain
inactiv
viru
administ
pup
week
age
second
dose
week
later
annual
revaccin
immun
develop
approxim
day
second
dose
vaccin
consid
recommend
dog
north
america
like
expos
part
lifestyl
anderson
et
al
time
write
local
outbreak
canin
influenza
attribut
viru
subtyp
report
chicago
wisconsin
region
usa
condit
licens
vaccin
subtyp
releas
first
canin
immunotherapeut
vaccin
malign
melanoma
licens
product
compris
human
tyrosinas
gene
incorpor
plasmid
nake
dna
vaccin
repeatedli
deliv
use
transderm
inject
devic
vaccin
use
adjunct
treatment
dog
oral
melanoma
induc
immun
respons
melanoma
target
antigen
initi
studi
show
median
surviv
time
dog
grade
melanoma
increas
day
expect
surviv
day
bergman
et
al
recent
studi
shown
lesser
effect
grosenbaugh
et
al
ottnod
et
al
vaccin
also
avail
europ
usa
limit
use
recogn
veterinari
oncolog
specialist
two
licens
vaccin
canin
leishmaniosi
recent
avail
brazil
leishmaniosi
diseas
major
import
canin
human
popul
first
subunit
product
contain
leishmania
donovani
also
known
fucos
mannos
ligand
fml
saponin
adjuv
consid
induc
antibodi
block
transmiss
organ
dog
sandfli
vector
prevent
bind
leishmania
midgut
sand
fli
extens
evalu
immunolog
epidemiolog
field
studi
palatnik
de
sousa
et
al
palatnik
de
sousa
day
howev
product
recent
withdrawn
brazilian
market
second
brazilian
vaccin
contain
antigen
l
donovani
saponin
adjuv
vaccin
report
induc
similar
protect
effect
vaccin
dog
ie
respect
seroconvers
prevent
infect
clinic
sign
transmiss
vector
fml
vaccin
compar
natur
exposur
field
trial
endem
area
month
period
dog
vaccin
vaccin
develop
lesser
humor
immun
respons
show
greater
frequenc
advers
event
post
vaccin
fernand
et
al
european
leishmania
vaccin
dog
introduc
bongiorno
et
al
moreno
et
al
vaccin
contain
antigen
leishmania
infantum
adjuv
vaccin
use
seroneg
dog
month
age
three
primari
dose
administ
week
apart
annual
booster
vaccin
dog
seroconvert
product
datasheet
describ
discriminatori
serolog
test
evid
immun
respons
also
suggest
vaccin
claim
reduc
likelihood
infect
reduc
sever
clinic
sign
infect
dog
make
public
health
claim
effect
human
diseas
preval
guidelin
recommend
core
recommend
option
recommend
vaccin
cat
visit
gener
veterinari
practic
given
tabl
core
vaccin
cat
protect
felin
panleukopenia
fpv
fcv
particular
exampl
vaccin
may
consid
core
countri
rabi
viru
geograph
area
infect
endem
vgg
recommend
cat
routin
vaccin
protect
pet
human
popul
countri
mandatori
rabi
vaccin
legal
requir
although
alway
includ
cat
rabi
vaccin
also
requir
intern
pet
travel
term
felin
core
vaccin
import
realiz
protect
afford
fcv
vaccin
match
immun
provid
fpv
vaccin
thu
felin
core
respiratori
diseas
vaccin
expect
give
robust
protect
durat
immun
seen
canin
core
vaccin
fcv
vaccin
design
produc
immun
multipl
strain
fcv
howev
still
possibl
infect
diseas
occur
vaccin
adult
anim
pedersen
et
al
et
al
vaccin
protect
infect
virul
viru
infect
may
lead
virul
viru
becom
latent
possibl
reactiv
period
sever
stress
richter
et
al
mae
reactiv
viru
may
caus
clinic
sign
vaccin
anim
viru
shed
suscept
anim
caus
diseas
vgg
recommend
triennial
revaccin
cat
fcv
basi
publish
studi
show
minimum
durat
partial
clinic
signific
immun
year
core
vaccin
scott
geissing
recent
studi
mlv
vaccin
seem
show
much
less
substanti
partial
protect
year
post
vaccin
although
fcv
partial
protect
compar
shown
scott
geissing
ja
et
al
vgg
recommend
annual
revaccin
cat
carri
situat
cat
might
defin
solitari
indoor
anim
visit
board
catteri
cat
might
defin
anim
regularli
visit
board
catteri
live
multicat
household
moreov
vgg
encourag
practition
consid
time
administr
vaccin
regularli
board
cat
robust
immun
confer
vaccin
occur
within
period
vaccin
gaskel
et
al
administr
vaccin
might
best
time
immedi
regularli
board
cat
due
make
annual
visit
catteri
vaccin
felin
leukaemia
viru
felv
also
often
point
debat
amongst
expert
vgg
regard
felv
vaccin
tabl
fulli
appreci
use
product
must
determin
lifestyl
perceiv
exposur
risk
individu
cat
preval
infect
local
environ
mani
felin
expert
believ
even
though
preval
felv
infect
markedli
reduc
mani
part
world
due
success
control
programm
weijer
daam
weijer
et
al
meichner
et
al
geograph
area
felv
infect
remain
preval
cat
less
year
old
element
outdoor
lifestyl
eg
even
live
cat
goe
outdoor
receiv
benefit
protect
routin
vaccin
two
dose
vaccin
given
week
apart
start
earlier
week
age
analysi
felv
form
routin
part
felin
vaccin
interview
cat
vaccin
vgg
also
reconsid
fiv
vaccin
previou
iter
guidelin
categor
recommend
basi
categor
question
subtyp
viru
includ
vaccin
subtyp
recombin
field
differ
geograph
area
hosi
et
al
dunham
et
al
yamamoto
et
al
coleman
et
al
beczkowski
et
al
interfer
vaccin
antibodi
test
use
diagnosi
fiv
infect
hosi
beatti
fact
adjuv
vaccin
must
given
repeatedli
primari
cours
three
inject
annual
revaccin
speci
suscept
inject
site
sarcoma
vgg
awar
part
world
remain
signific
preval
fiv
seroposit
andor
infect
bennett
et
al
hosi
et
al
friend
et
al
glennon
et
al
bandecchi
et
al
hitt
et
al
ueland
lutz
jone
et
al
et
al
yilmaz
et
al
lee
et
al
muirden
norri
et
al
gleich
et
al
ravi
et
al
band
et
al
chang
fung
martel
et
al
rypula
et
al
discriminatori
serolog
test
kusuhara
et
al
levi
et
al
westman
et
al
robust
polymeras
chain
reaction
pcr
test
diagnosi
fiv
infect
arjona
et
al
wang
et
al
morton
et
al
mani
countri
unlik
cat
owner
persuad
keep
cat
indoor
away
major
risk
fiv
transmiss
bite
infect
cat
diseas
progress
cat
recent
shown
impact
hous
condit
number
cat
household
beczkowski
et
al
given
vaccin
shown
efficaci
studi
other
might
benefit
popul
cat
vgg
reclassifi
product
vaccin
discuss
puppi
kitten
protect
mda
first
week
life
howev
without
serolog
test
level
protect
point
kitten
becom
suscept
infect
respond
immunolog
vaccin
unknown
relat
level
matern
antibodi
variat
uptak
mda
litter
individu
gener
mda
wane
week
age
level
allow
activ
immunolog
respons
howev
kitten
poor
mda
may
vulner
capabl
respond
vaccin
earlier
age
other
may
possess
mda
high
titr
incap
respond
vaccin
sometim
week
age
vgg
review
recent
studi
suggest
one
third
kitten
may
fail
respond
final
core
vaccin
given
week
age
proport
kitten
may
still
block
mda
week
age
digangi
et
al
jakel
et
al
vgg
note
one
studi
rel
low
number
anim
domin
one
breed
within
catteri
set
suggest
data
may
fulli
applic
wider
felin
popul
nevertheless
vgg
increas
recommend
age
final
vaccin
seri
primari
core
vaccin
week
age
week
older
vgg
recommend
core
vaccin
kitten
therefor
line
schedul
propos
puppi
begin
week
age
repeat
vaccin
everi
week
week
age
older
therefor
number
kitten
primari
core
vaccin
determin
age
vaccin
start
chosen
revaccin
interv
possibl
schedul
outlin
tabl
recommend
vaccin
start
week
age
cours
four
primari
core
vaccin
would
administ
three
would
requir
start
integr
part
core
vaccin
kitten
booster
vaccin
tradit
given
either
month
age
month
last
primari
seri
kitten
vaccin
main
aim
vaccin
ensur
protect
immun
respons
develop
cat
may
fail
respond
three
vaccin
primari
core
seri
rather
necessarili
boost
immun
respons
deliveri
vaccin
month
age
like
chosen
histor
conveni
time
request
owner
attend
practic
first
annual
health
check
therefor
impli
individu
kitten
fail
respond
three
primari
core
vaccin
kitten
may
unprotect
receiv
vaccin
might
account
occurr
infecti
diseas
proport
vaccin
kitten
less
month
age
vgg
practic
suggest
veterinarian
might
wish
reduc
possibl
window
suscept
bring
forward
vaccin
week
week
age
inde
time
point
week
age
howev
week
age
provid
conveni
time
practic
requir
pet
owner
clearli
understand
recommend
indic
tabl
adopt
protocol
mean
vaccin
start
week
old
kitten
might
entail
five
vaccin
visit
first
month
life
core
vaccin
week
booster
anoth
core
vaccin
would
requir
least
anoth
year
cat
puppi
adopt
week
vaccin
approach
would
preclud
first
annual
health
check
month
age
cat
respond
vaccin
mlv
core
vaccin
maintain
solid
immun
immunolog
memori
fpv
mani
year
absenc
repeat
vaccin
immun
fcv
partial
scott
geissing
ja
et
al
vgg
recommend
adult
cat
revaccin
mlv
core
vaccin
interv
year
longer
cat
see
definit
veterinarian
might
consid
administ
fpv
vaccin
frequent
everi
year
give
fcv
vaccin
annual
latter
product
time
administr
shortli
regular
annual
visit
board
catteri
recommend
gener
appli
kill
core
vaccin
except
rabi
vaccin
particularli
vaccin
contain
bacteri
antigen
thu
chlamydia
formerli
chlamydophila
sachs
et
al
bordetella
product
use
deem
necessari
requir
annual
booster
limit
protect
afford
product
therefor
accord
guidelin
adult
cat
may
still
receiv
annual
vaccin
howev
compon
vaccin
may
differ
year
year
typic
core
vaccin
especi
fpv
current
administ
triennial
respiratori
viru
vaccin
given
accord
risk
chosen
product
given
annual
vgg
awar
countri
product
contain
core
combin
avail
vgg
would
encourag
manufactur
make
full
rang
vaccin
avail
wherev
possibl
least
make
combin
want
give
vaccin
adult
cat
receiv
complet
cours
vaccin
fpv
fcv
kitten
includ
booster
may
regularli
vaccin
adult
requir
singl
dose
mlv
core
vaccin
boost
immun
adopt
adult
cat
kitten
week
age
unknown
vaccin
histori
requir
singl
dose
mlv
fpv
core
vaccin
engend
protect
immun
respons
viru
contrast
adopt
adult
cat
unknown
vaccin
histori
receiv
two
dose
mlv
vaccin
week
apart
establish
adequ
immun
respons
vaccin
type
one
class
inject
product
link
pathogenesi
felin
inject
site
sarcoma
fiss
particular
attent
focus
administr
adjuv
felv
rabi
vaccin
kass
et
al
fiss
subject
much
research
number
recent
review
subject
martano
et
al
srivastav
et
al
ladlow
hartmann
et
al
although
pathogenesi
fiss
remain
unproven
current
belief
local
chronic
inflammatori
reaction
initi
malign
transform
mesenchym
cell
process
genet
basi
subcutan
inject
includ
vaccin
tradit
given
interscapular
region
cat
remain
common
site
format
fiss
infiltr
natur
tumour
mean
radic
surgic
resect
often
necessari
attempt
remov
lesion
although
adjunct
treatment
modal
also
use
martano
et
al
ladlow
north
america
respons
issu
recommend
protocol
wherebi
two
perceiv
adjuv
vaccin
would
administ
distinct
anatom
site
would
amen
surgic
remov
fiss
might
develop
accordingli
recommend
left
leg
leukaemia
right
leg
rabi
suggest
felv
vaccin
given
far
distal
possibl
left
hindlimb
whilst
rabi
vaccin
given
far
distal
possibl
right
hindlimb
recommend
remain
current
aafp
guidelin
scherk
et
al
also
specifi
administr
three
felin
core
vaccin
distal
forelimb
one
studi
evalu
effect
practic
compar
anatom
distribut
fiss
cat
recommend
made
practic
adopt
shaw
et
al
data
show
signific
decreas
preval
interscapular
fiss
increas
preval
tumour
right
left
forelimb
notabl
also
increas
number
tumour
report
aris
combin
region
right
hindlimb
right
later
aspect
abdomen
left
hindlimb
left
later
aspect
abdomen
attribut
difficultli
inject
distal
hindlimb
abdomin
site
accident
inject
practic
wide
adopt
outsid
north
america
recent
one
public
shown
efficaci
administ
fpv
rabi
vaccin
tail
cat
hendrick
et
al
adult
cat
commun
programm
given
trival
mlv
core
vaccin
fpv
fcv
distal
third
dorsal
tail
inactiv
rabi
vaccin
administ
cm
distal
site
trival
vaccin
seroconvers
occur
cat
fpv
one
cat
rabi
viru
tail
vaccin
report
well
toler
cat
small
studi
wsava
vaccin
guidelin
vgg
propos
altern
deliv
vaccin
skin
later
thorax
better
later
abdomen
day
et
al
tail
inject
may
prove
safer
altern
distal
limb
inject
later
bodi
wall
inject
studi
tail
vaccin
requir
remain
confus
contenti
area
individu
practition
must
decid
approach
practic
practic
set
howev
follow
principl
still
appli
risk
fiss
outweigh
benefit
protect
immun
confer
vaccin
current
estim
preval
fiss
everi
cat
vaccin
gobar
kass
dean
et
al
vaccin
administ
cat
wherev
possiblevaccin
particularli
adjuv
product
inject
administ
interscapular
regionvaccin
particularli
adjuv
product
administ
subcutan
intramuscular
site
choic
site
base
balanc
eas
surgic
resect
fiss
might
develop
accept
safeti
vaccin
ie
avoid
accident
difficult
restraint
anim
vaccin
administ
differ
site
occas
site
record
patient
record
vaccin
card
use
diagram
indic
product
administ
one
occas
site
rotat
occas
altern
practic
might
develop
group
polici
felin
vaccin
administ
specif
site
one
calendar
year
site
rotat
follow
yearth
vgg
encourag
case
suspect
fiss
notifi
via
appropri
nation
report
rout
suspect
advers
reaction
vaccin
manufactur
sinc
public
guidelin
one
commerci
rapid
test
determin
serum
antibodi
fpv
fcv
becom
avail
test
valid
appli
seri
publish
investig
digangi
et
al
mend
et
al
test
kit
may
use
determin
presenc
protect
antibodi
fpv
excel
correl
presenc
antibodi
resist
infect
lappin
et
al
fpv
test
kit
report
specif
sensit
mend
et
al
specif
sensit
digangi
et
al
compar
haemagglutin
inhibit
test
neg
test
result
indic
cat
littl
antibodi
revaccin
recommend
howev
seroneg
cat
fact
immun
revaccin
would
unnecessari
contrast
posit
test
result
would
lead
conclus
revaccin
requir
correl
circul
serum
antibodi
protect
fcv
infect
less
robust
presenc
adequ
local
mucos
immun
immun
respect
reason
neg
test
result
fcv
antibodi
would
necessarili
indic
lack
protect
particular
cat
lappin
et
al
test
appli
practic
describ
dog
determin
protect
kitten
follow
fpv
vaccin
determin
protect
fpv
adult
cat
order
inform
decis
revaccin
use
shelter
situat
control
outbreak
fpv
infect
emphas
antibodi
test
fiv
use
diagnos
diseas
valu
determin
immun
fiv
discuss
fiv
vaccin
use
fiv
infect
suspect
diagnosi
made
use
discriminatori
serolog
test
prefer
valid
pcr
test
anim
shelter
hold
facil
anim
usual
await
adopt
rescu
reclam
owner
gener
anim
shelter
character
random
sourc
popul
mostli
unknown
vaccin
histori
high
popul
turnov
high
infecti
diseas
risk
term
shelter
encompass
situat
rang
sanctuari
possess
stabl
popul
facil
admit
hundr
anim
per
day
rescu
foster
home
care
multipl
individu
litter
given
time
vaccin
strategi
vari
individu
pet
strategi
vaccin
shelter
anim
likelihood
exposur
potenti
devast
consequ
infect
necessit
clearli
defin
shelter
vaccin
program
shelter
medicin
differ
individu
care
clinician
practic
environ
erad
infecti
diseas
attain
possibl
howev
minim
spread
infect
within
popul
maintain
health
individu
overal
purpos
place
healthi
pet
welcom
home
time
effort
dedic
control
infecti
diseas
one
mani
variabl
complex
shelter
medicin
husbandri
equat
recommend
provid
attempt
address
issu
pertain
vaccin
diseas
control
guidelin
recommend
vaccin
use
shelter
given
tabl
updat
guidelin
standard
recommend
puppi
kitten
enter
shelter
indic
core
vaccin
may
start
earli
week
age
fund
permit
revaccin
everi
week
anim
reach
week
age
remain
shelter
time
recent
us
studi
shown
cat
enter
shelter
may
seroposit
infecti
diseas
agent
digangi
et
al
report
seroposit
fpv
fcv
fischer
et
al
report
seroposit
fpv
fcv
rabi
viru
seroposit
cdv
less
cpv
dog
enter
one
us
shelter
litster
et
al
anoth
studi
dog
seroposit
cdv
cpv
cdv
cpv
neither
viru
lechner
et
al
unambigu
document
vaccin
provid
adult
anim
time
admiss
shelter
reason
revaccin
canin
core
vaccin
felin
core
vaccin
specif
fcv
may
valu
boost
immun
vgg
discrimin
shelter
board
kennelcatteri
latter
facil
fulli
vaccin
anim
may
temporarili
board
rel
short
period
time
eg
owner
vacat
requir
entri
facil
individu
dog
cat
fulli
vaccin
core
product
given
accord
guidelin
present
herein
dog
use
vaccin
respiratori
infect
also
appropri
circumst
vgg
awar
countri
vaccin
protocol
anim
enter
board
kennelcatteri
formul
local
author
may
contrari
current
guidelin
eg
insist
annual
revaccin
vgg
encourag
author
reconsid
recommend
light
current
scientif
think
product
avail
encourag
veterinari
profess
nation
associ
lobbi
chang
sinc
public
guidelin
avail
rapid
serolog
test
kit
major
impact
manag
outbreak
cdv
cpv
fpv
anim
shelter
approach
use
kit
situat
outlin
tabl
past
veterinari
practic
benefit
annual
administr
vaccin
encourag
owner
bring
pet
yearli
vaccin
veterinarian
abl
recogn
treat
diseas
earlier
might
otherwis
case
addit
annual
visit
provid
opportun
inform
client
import
aspect
canin
felin
health
care
unfortun
mani
client
come
believ
vaccin
import
reason
annual
veterinari
visit
veterinarian
concern
reduct
vaccin
frequenc
caus
client
forgo
annual
visit
qualiti
care
diminish
therefor
essenti
veterinarian
stress
import
aspect
comprehens
individu
health
care
program
emphasi
place
detail
histori
take
thorough
physic
examin
perform
presenc
client
individu
patient
care
import
dental
care
proper
nutrit
appropri
diagnost
test
control
parasit
zoonot
diseas
address
evalu
pet
behaviour
concern
discuss
well
necess
frequent
tailor
examin
young
geriatr
anim
anim
particular
breed
well
character
diseas
predisposit
discuss
vaccin
simpli
one
part
annual
health
check
visit
regular
usual
annual
health
check
clinician
assess
need
core
vaccin
particular
year
practition
explain
client
type
vaccin
avail
potenti
benefit
risk
applic
particular
anim
given
lifestyl
risk
exposur
anim
might
receiv
core
vaccin
everi
year
vaccin
requir
annual
administr
owner
continu
see
anim
vaccin
annual
region
incid
risk
factor
variou
infecti
diseas
also
discuss
way
reduc
impact
acquir
diseas
eg
avoid
overcrowd
improv
nutrit
restrict
access
infect
anim
also
review
vaccin
consid
one
compon
comprehens
prevent
health
care
plan
individu
base
age
breed
health
statu
environ
potenti
exposur
harm
agent
lifestyl
contact
anim
travel
habit
pet
age
signific
effect
prevent
health
care
need
given
individu
puppykitten
program
tradit
focus
vaccin
parasit
control
neuter
today
opportun
exist
incorpor
behaviour
counsel
zoonot
diseas
manag
age
pet
senior
care
program
becom
increasingli
popular
nutrit
dental
diseas
parasit
control
assess
counsel
take
place
individu
basi
throughout
life
pet
evid
older
dog
cat
fulli
vaccin
pup
kitten
requir
special
programm
core
vaccin
day
horzinek
schultz
et
al
experiment
evid
show
older
dog
cat
persist
immunolog
memori
core
vaccin
detect
measur
serum
antibodi
may
readili
boost
administr
singl
vaccin
dose
day
adult
anim
decis
revaccin
core
product
cdv
cav
cpv
fpv
may
made
via
serolog
test
practition
offer
altern
vaccin
report
greatli
appreci
owner
may
concern
vaccin
frequenc
offer
altern
act
practic
builder
contrast
age
anim
may
effici
mount
primari
immun
respons
novel
antigen
previous
encount
day
studi
uk
dog
cat
vaccin
first
time
rabi
pet
travel
clearli
shown
age
anim
fail
achiev
legal
requir
antibodi
titr
kennedi
et
al
environ
pet
resid
profoundli
affect
health
statu
assess
annual
health
care
visit
order
defin
risk
factor
develop
appropri
prevent
measur
estim
extent
dog
cat
come
contact
anim
unobserv
circumst
veterinarian
assess
need
vaccin
dog
visit
kennel
groom
salon
common
area
wood
area
potenti
greater
risk
certain
infecti
diseas
dog
frequent
area
human
popul
becom
mobil
pet
popul
result
potenti
exposur
infecti
agent
parasit
environment
hazard
found
anim
normal
live
determin
past
anticip
futur
travel
visit
allow
greater
individu
prevent
care
diagnost
test
plan
time
vaccin
administr
follow
inform
record
patient
perman
medic
record
date
vaccin
administrationident
name
initi
code
person
administ
vaccinevaccin
name
lot
serial
number
expiri
date
manufacturersit
rout
vaccin
administr
use
vaccin
label
stamp
imprint
medic
record
outlin
pet
facilit
type
record
keep
mandatori
countri
advers
event
record
manner
alert
staff
member
futur
visit
inform
consent
document
medic
record
order
demonstr
relev
inform
provid
client
client
author
procedur
eg
use
product
discuss
least
notat
indic
discuss
risk
benefit
took
place
prior
vaccin
vgg
recommend
vaccin
certif
design
includ
date
vaccin
administ
also
field
veterinarian
state
date
vaccin
next
recommend
help
diminish
confus
mind
pet
owner
kennelcatteri
proprietor
advers
event
defin
side
effect
unintend
consequ
includ
lack
protect
associ
administr
vaccin
product
includ
injuri
toxic
hypersensit
reaction
associ
vaccin
whether
event
directli
attribut
vaccin
advers
event
report
whether
associ
vaccin
recogn
suspect
vaccin
advers
event
report
identifi
product
anim
involv
event
individu
submit
report
report
field
observ
unexpect
vaccin
perform
import
mean
manufactur
regulatori
agenc
alert
potenti
vaccin
safeti
efficaci
problem
may
warrant
investig
purpos
safeti
studi
detect
rel
common
advers
event
rare
delay
advers
event
detect
surveil
analysi
report
advers
event
advers
event
report
manufactur
andor
local
regulatori
author
mani
countri
government
surveil
scheme
avail
reaction
therefor
notifi
manufactur
vgg
recogn
gross
advers
event
passiv
natur
report
scheme
imped
knowledg
ongo
safeti
product
vgg
would
activ
encourag
veterinarian
particip
surveil
scheme
particular
advers
event
well
document
report
serv
provid
baselin
futur
report
compar
addit
report
advers
event
lead
detect
previous
unrecogn
reaction
detect
increas
known
reaction
recognit
risk
factor
associ
reaction
identif
vaccin
lot
unusu
event
higher
number
advers
event
stimul
clinic
epidemiolog
laboratori
studi
therefor
veterinarian
encourag
report
clinic
signific
advers
event
occur
administr
licens
vaccin
report
vaccin
advers
event
indict
particular
vaccin
facilit
review
tempor
associ
condit
add
safeti
databas
product
